abstract |
The present invention relates to chemotherapeutic agents for treating viral and cancerous diseases. The present compounds are prodrugs of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) DNA polymerase inhibitors, and are intended for treating the human immunodeficiency virus, hepatitis B, and co-infections of HIV/HCV, HIV/HBV, HIV/HCV/HBV and HCV/HBV. |